(Q39234393)

10 September 2017

Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth (English)

1 reference

10 September 2017

1 reference

1 reference

13

Cédric Rébé

0 references

François Ghiringhelli

15

François Ghiringhelli

0 references

Lionel Apetoh

14

Lionel Apetoh

0 references

Valentin Derangère

3

Valentin Derangère

0 references

Mélanie Bruchard

1

Mélanie Bruchard

0 references

Bernhard Ryffel

9

Bernhard Ryffel

0 references

François Martin

12

François Martin

0 references

Grégoire Mignot

2

Grégoire Mignot

0 references

author name string

Fanny Chalmin

4

1 reference

10 September 2017

Angélique Chevriaux

5

1 reference

10 September 2017

Frédérique Végran

6

1 reference

10 September 2017

Wilfrid Boireau

7

1 reference

10 September 2017

Benoit Simon

8

1 reference

10 September 2017

Jean Louis Connat

10

1 reference

10 September 2017

Jean Kanellopoulos

11

1 reference

10 September 2017

language of work or name

English

0 references

publication date

2 December 2012

1 reference

10 September 2017

1 reference

10 September 2017

19

1 reference

10 September 2017

1

1 reference

10 September 2017

57-64

1 reference

https://scigraph.springernature.com/pub.10.1038/nm.2999

10 September 2017

0 references

cites work

Effector memory T cells, early metastasis, and survival in colorectal cancer

1 reference

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

21 January 2018

1 reference

Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors

21 January 2018

1 reference

Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity

21 January 2018

1 reference

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors

21 January 2018

1 reference

Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice

21 January 2018

1 reference

Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice.

21 January 2018

1 reference

5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity

21 January 2018

1 reference

Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity

21 January 2018

1 reference

Restoration of antitumor immunity through selective inhibition of myeloid derived suppressor cells by anticancer therapies

21 January 2018

1 reference

Myeloid-derived suppressor cells: linking inflammation and cancer

21 January 2018

1 reference

Myeloid-derived suppressor cells as regulators of the immune system

21 January 2018

1 reference

Tumor escape mechanism governed by myeloid-derived suppressor cells

21 January 2018

1 reference

5-Fluorouracil: mechanisms of action and clinical strategies

21 January 2018

1 reference

Cellular pharmacology of gemcitabine

21 January 2018

1 reference

The inflammasome: an integrated view

21 January 2018

1 reference

The inflammasome: a danger sensing complex triggering innate immunity

21 January 2018

1 reference

NALPs: a novel protein family involved in inflammation

21 January 2018

1 reference

Why not treat human cancer with interleukin-1 blockade?

21 January 2018

1 reference

Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells

21 January 2018

1 reference

Critical regulation of early Th17 cell differentiation by interleukin-1 signaling

21 January 2018

1 reference

TGF-beta promotes Th17 cell development through inhibition of SOCS3.

21 January 2018

1 reference

IL-17 promotes tumor development through the induction of tumor promoting microenvironments at tumor sites and myeloid-derived suppressor cells

21 January 2018

1 reference

Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice

21 January 2018

1 reference

Predominant requirement of Bax for apoptosis in HCT116 cells is determined by Mcl-1's inhibitory effect on Bak.

21 January 2018

1 reference

Microenvironment-derived IL-1 and IL-17 interact in the control of lung metastasis

21 January 2018

1 reference

Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy?

21 January 2018

1 reference

Immunity, Inflammation, and Cancer

21 January 2018

1 reference

The unholy trinity: inflammation, cytokines, and STAT3 shape the cancer microenvironment

21 January 2018

1 reference

Inflammation and cancer: a double-edged sword.

21 January 2018

1 reference

IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer

21 January 2018

1 reference

Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production

21 January 2018

1 reference

Smoldering and polarized inflammation in the initiation and promotion of malignant disease

21 January 2018

1 reference

Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression

21 January 2018

1 reference

The inflammasome component NLRP3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cells

21 January 2018

1 reference

IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway

21 January 2018

1 reference

Immunological aspects of cancer chemotherapy

21 January 2018

1 reference

Calreticulin exposure dictates the immunogenicity of cancer cell death

21 January 2018

1 reference

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice

21 January 2018

1 reference

Revisited BIA-MS combination: entire "on-a-chip" processing leading to the proteins identification at low femtomole to sub-femtomole levels

21 January 2018

1 reference

Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response

21 January 2018

1 reference

12 December 2020

CA074 methyl ester: a proinhibitor for intracellular cathepsin B

1 reference

12 December 2020

Interleukin-17 promotes angiogenesis and tumor growth

1 reference

12 December 2020

Interleukin-1β–Driven Inflammation Promotes the Development and Invasiveness of Chemical Carcinogen–Induced Tumors

1 reference

12 December 2020

Identifiers

DOI

10.1038/NM.2999

1 reference

10 September 2017

1 reference